TY - JOUR
T1 - Suitability and Allocation of Protein-Containing Foods According to Protein Tolerance in PKU
T2 - A 2022 UK National Consensus
AU - Gama, Maria Inês
AU - Adam, Sarah
AU - Adams, Sandra
AU - Allen, Heather
AU - Ashmore, Catherine
AU - Bailey, Sarah
AU - Cochrane, Barbara
AU - Dale, Clare
AU - Daly, Anne
AU - De Sousa, Giana
AU - Donald, Sarah
AU - Dunlop, Carolyn
AU - Ellerton, Charlotte
AU - Evans, Sharon
AU - Firman, Sarah
AU - Ford, Suzanne
AU - Freedman, Francine
AU - French, Moira
AU - Gaff, Lisa
AU - Gribben, Joanna
AU - Grimsley, Anne
AU - Herlihy, Ide
AU - Hill, Melanie
AU - Khan, Farzana
AU - McStravick, Nicola
AU - Millington, Chloe
AU - Moran, Nicola
AU - Newby, Camille
AU - Nguyen, Patty
AU - Purves, Janet
AU - Pinto, Alex
AU - Rocha, Júlio César
AU - Skeath, Rachel
AU - Skelton, Amy
AU - Tapley, Simon
AU - Woodall, Alison
AU - Young, Carla
AU - MacDonald, Anita
N1 - Funding Information:
No funding was required for this project. All work was conducted as part of routine service by all dietitians involved.
Publisher Copyright:
© 2022 by the authors.
PY - 2022/12
Y1 - 2022/12
N2 - Introduction: There is little practical guidance about suitable food choices for higher natural protein tolerances in patients with phenylketonuria (PKU). This is particularly important to consider with the introduction of adjunct pharmaceutical treatments that may improve protein tolerance. Aim: To develop a set of guidelines for the introduction of higher protein foods into the diets of patients with PKU who tolerate >10 g/day of protein. Methods: In January 2022, a 26-item food group questionnaire, listing a range of foods containing protein from 5 to >20 g/100 g, was sent to all British Inherited Metabolic Disease Group (BIMDG) dietitians (n = 80; 26 Inherited Metabolic Disease [IMD] centres). They were asked to consider within their IMD dietetic team when they would recommend introducing each of the 26 protein-containing food groups into a patient’s diet who tolerated >10 g to 60 g/day of protein. The patient protein tolerance for each food group that received the majority vote from IMD dietetic teams was chosen as its tolerance threshold for introduction. A virtual meeting was held using Delphi methodology in March 2022 to discuss and agree final consensus. Results: Responses were received from dietitians from 22/26 IMD centres (85%) (11 paediatric, 11 adult). For patients tolerating protein ≥15 g/day, the following foods were agreed for inclusion: gluten-free pastas, gluten-free flours, regular bread, cheese spreads, soft cheese, and lentils in brine; for protein tolerance ≥20 g/day: nuts, hard cheeses, regular flours, meat/fish, and plant-based alternative products (containing 5–10 g/100 g protein), regular pasta, seeds, eggs, dried legumes, and yeast extract spreads were added; for protein tolerance ≥30 g/day: meat/fish and plant-based alternative products (containing >10–20 g/100 g protein) were added; and for protein tolerance ≥40 g/day: meat/fish and plant-based alternatives (containing >20 g/100 g protein) were added. Conclusion: This UK consensus by IMD dietitians from 22 UK centres describes for the first time the suitability and allocation of higher protein foods according to individual patient protein tolerance. It provides valuable guidance for health professionals to enable them to standardize practice and give rational advice to patients.
AB - Introduction: There is little practical guidance about suitable food choices for higher natural protein tolerances in patients with phenylketonuria (PKU). This is particularly important to consider with the introduction of adjunct pharmaceutical treatments that may improve protein tolerance. Aim: To develop a set of guidelines for the introduction of higher protein foods into the diets of patients with PKU who tolerate >10 g/day of protein. Methods: In January 2022, a 26-item food group questionnaire, listing a range of foods containing protein from 5 to >20 g/100 g, was sent to all British Inherited Metabolic Disease Group (BIMDG) dietitians (n = 80; 26 Inherited Metabolic Disease [IMD] centres). They were asked to consider within their IMD dietetic team when they would recommend introducing each of the 26 protein-containing food groups into a patient’s diet who tolerated >10 g to 60 g/day of protein. The patient protein tolerance for each food group that received the majority vote from IMD dietetic teams was chosen as its tolerance threshold for introduction. A virtual meeting was held using Delphi methodology in March 2022 to discuss and agree final consensus. Results: Responses were received from dietitians from 22/26 IMD centres (85%) (11 paediatric, 11 adult). For patients tolerating protein ≥15 g/day, the following foods were agreed for inclusion: gluten-free pastas, gluten-free flours, regular bread, cheese spreads, soft cheese, and lentils in brine; for protein tolerance ≥20 g/day: nuts, hard cheeses, regular flours, meat/fish, and plant-based alternative products (containing 5–10 g/100 g protein), regular pasta, seeds, eggs, dried legumes, and yeast extract spreads were added; for protein tolerance ≥30 g/day: meat/fish and plant-based alternative products (containing >10–20 g/100 g protein) were added; and for protein tolerance ≥40 g/day: meat/fish and plant-based alternatives (containing >20 g/100 g protein) were added. Conclusion: This UK consensus by IMD dietitians from 22 UK centres describes for the first time the suitability and allocation of higher protein foods according to individual patient protein tolerance. It provides valuable guidance for health professionals to enable them to standardize practice and give rational advice to patients.
KW - national consensus
KW - phenylalanine
KW - Phenylketonuria
KW - protein
KW - sapropterin
UR - http://www.scopus.com/inward/record.url?scp=85143601512&partnerID=8YFLogxK
U2 - 10.3390/nu14234987
DO - 10.3390/nu14234987
M3 - Article
C2 - 36501017
AN - SCOPUS:85143601512
SN - 1422-8599
VL - 14
JO - Nutrients
JF - Nutrients
IS - 23
M1 - 4987
ER -